Copyright Reports & Markets. All rights reserved.

Global Human Immunodeficiency Virus Type-1 Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Human Immunodeficiency Virus Type-1 by Type
    • 1.3.1 Overview: Global Human Immunodeficiency Virus Type-1 Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Human Immunodeficiency Virus Type-1 Consumption Value Market Share by Type in 2025
    • 1.3.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    • 1.3.4 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
    • 1.3.5 Protease Inhibitors (PIs)
    • 1.3.6 Integrase Inhibitor
    • 1.3.7 Others
  • 1.4 Global Human Immunodeficiency Virus Type-1 Market by Application
    • 1.4.1 Overview: Global Human Immunodeficiency Virus Type-1 Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
  • 1.5 Global Human Immunodeficiency Virus Type-1 Market Size & Forecast
  • 1.6 Global Human Immunodeficiency Virus Type-1 Market Size and Forecast by Region
    • 1.6.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Human Immunodeficiency Virus Type-1 Market Size by Region, (2021-2032)
    • 1.6.3 North America Human Immunodeficiency Virus Type-1 Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Human Immunodeficiency Virus Type-1 Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size and Prospect (2021-2032)
    • 1.6.6 South America Human Immunodeficiency Virus Type-1 Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.1.4 Roche Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Bristol Myers Squibb
    • 2.2.1 Bristol Myers Squibb Details
    • 2.2.2 Bristol Myers Squibb Major Business
    • 2.2.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.2.4 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bristol Myers Squibb Recent Developments and Future Plans
  • 2.3 Merck & Co. Inc.
    • 2.3.1 Merck & Co. Inc. Details
    • 2.3.2 Merck & Co. Inc. Major Business
    • 2.3.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.3.4 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck & Co. Inc. Recent Developments and Future Plans
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.4.4 GSK Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GSK Recent Developments and Future Plans
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.5.4 Pfizer Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Recent Developments and Future Plans
  • 2.6 Viatris
    • 2.6.1 Viatris Details
    • 2.6.2 Viatris Major Business
    • 2.6.3 Viatris Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.6.4 Viatris Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Viatris Recent Developments and Future Plans
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.7.4 Sanofi Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sanofi Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.8.4 AstraZeneca Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.9.4 Novartis Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Bayer
    • 2.10.1 Bayer Details
    • 2.10.2 Bayer Major Business
    • 2.10.3 Bayer Human Immunodeficiency Virus Type-1 Product and Solutions
    • 2.10.4 Bayer Human Immunodeficiency Virus Type-1 Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bayer Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Human Immunodeficiency Virus Type-1 Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Human Immunodeficiency Virus Type-1 by Company Revenue
    • 3.2.2 Top 3 Human Immunodeficiency Virus Type-1 Players Market Share in 2025
    • 3.2.3 Top 6 Human Immunodeficiency Virus Type-1 Players Market Share in 2025
  • 3.3 Human Immunodeficiency Virus Type-1 Market: Overall Company Footprint Analysis
    • 3.3.1 Human Immunodeficiency Virus Type-1 Market: Region Footprint
    • 3.3.2 Human Immunodeficiency Virus Type-1 Market: Company Product Type Footprint
    • 3.3.3 Human Immunodeficiency Virus Type-1 Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Human Immunodeficiency Virus Type-1 Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Human Immunodeficiency Virus Type-1 Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Human Immunodeficiency Virus Type-1 Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Human Immunodeficiency Virus Type-1 Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Human Immunodeficiency Virus Type-1 Consumption Value by Type (2021-2032)
  • 6.2 North America Human Immunodeficiency Virus Type-1 Market Size by Application (2021-2032)
  • 6.3 North America Human Immunodeficiency Virus Type-1 Market Size by Country
    • 6.3.1 North America Human Immunodeficiency Virus Type-1 Consumption Value by Country (2021-2032)
    • 6.3.2 United States Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Human Immunodeficiency Virus Type-1 Consumption Value by Type (2021-2032)
  • 7.2 Europe Human Immunodeficiency Virus Type-1 Consumption Value by Application (2021-2032)
  • 7.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Country
    • 7.3.1 Europe Human Immunodeficiency Virus Type-1 Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 7.3.3 France Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Human Immunodeficiency Virus Type-1 Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region
    • 8.3.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Consumption Value by Region (2021-2032)
    • 8.3.2 China Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 8.3.5 India Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Human Immunodeficiency Virus Type-1 Consumption Value by Type (2021-2032)
  • 9.2 South America Human Immunodeficiency Virus Type-1 Consumption Value by Application (2021-2032)
  • 9.3 South America Human Immunodeficiency Virus Type-1 Market Size by Country
    • 9.3.1 South America Human Immunodeficiency Virus Type-1 Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Human Immunodeficiency Virus Type-1 Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country
    • 10.3.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Human Immunodeficiency Virus Type-1 Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Human Immunodeficiency Virus Type-1 Market Drivers
  • 11.2 Human Immunodeficiency Virus Type-1 Market Restraints
  • 11.3 Human Immunodeficiency Virus Type-1 Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Human Immunodeficiency Virus Type-1 Industry Chain
  • 12.2 Human Immunodeficiency Virus Type-1 Upstream Analysis
  • 12.3 Human Immunodeficiency Virus Type-1 Midstream Analysis
  • 12.4 Human Immunodeficiency Virus Type-1 Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Immunodeficiency Virus Type-1 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Human Immunodeficiency Virus Type-1 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Immunodeficiency Virus Type-1 market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Human Immunodeficiency Virus Type-1 market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Human Immunodeficiency Virus Type-1 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Human Immunodeficiency Virus Type-1 market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Immunodeficiency Virus Type-1
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Immunodeficiency Virus Type-1 market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Human Immunodeficiency Virus Type-1 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
    Protease Inhibitors (PIs)
    Integrase Inhibitor
    Others
    Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Market segment by players, this report covers
    Roche
    Bristol Myers Squibb
    Merck & Co. Inc.
    GSK
    Pfizer
    Viatris
    Sanofi
    AstraZeneca
    Novartis
    Bayer
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Human Immunodeficiency Virus Type-1 product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Human Immunodeficiency Virus Type-1, with revenue, gross margin, and global market share of Human Immunodeficiency Virus Type-1 from 2021 to 2026.
    Chapter 3, the Human Immunodeficiency Virus Type-1 competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Human Immunodeficiency Virus Type-1 market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Human Immunodeficiency Virus Type-1.
    Chapter 13, to describe Human Immunodeficiency Virus Type-1 research findings and conclusion.

    Buy now